Cancer, Trauma, and Stroke
Imaging Biomarkers are Changing Them All
Michael W. Vannier, M.D.
Diagnostic Radiology Department
University of Chicago Medical Center
Friday, April 17, 2009
10:30 a.m., Green Auditorium
VTC to Boulder will be Room 1107
You might think that imaging biomarkers are the holy grail of clinical medicine or that some advocates have overstated their potential. But, despite a conspicuous lack of standards, balkanization of specialty medicine, a faltering economy, and some initial missteps, imaging biomarkers are fundamental to achieving the promise of personalized medicine. The need for imaging biomarkers arises from an aging population, cost concerns, idiosyncratic effects of drugs, and technological opportunities. We could move a lot faster if a few impediments were addressed. Time is not on our side, so action is needed sooner than later.
Anyone outside NIST wishing to attend must be sponsored by a NIST employee and receive a visitor badge. For more information, call Kum J. Ham at 301-975-4203.
Colloquia are videotaped and available in the NIST Research Library.